Renal perturbations with sodium-glucose cotransporter 2 inhibitor in heart failure with preserved ejection fraction.

作者信息

Vanhentenrijk Simon, Tang W H Wilson

机构信息

Kaufman Center for Heart Failure Treatment and Recovery, Department of Cardiovascular Medicine, Heart Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, OH, USA.

出版信息

Eur J Heart Fail. 2024 Apr;26(4):897-899. doi: 10.1002/ejhf.3205. Epub 2024 Mar 19.

DOI:10.1002/ejhf.3205

PMID:38501484

Abstract

摘要

相似文献

Renal perturbations with sodium-glucose cotransporter 2 inhibitor in heart failure with preserved ejection fraction.

Eur J Heart Fail. 2024 Apr;26(4):897-899. doi: 10.1002/ejhf.3205. Epub 2024 Mar 19.

Renal effects of sodium-glucose co-transporter-2 inhibitors in patients with heart failure with reduced or preserved ejection fraction.钠-葡萄糖协同转运蛋白2抑制剂对射血分数降低或保留的心力衰竭患者的肾脏影响

Nefrologia (Engl Ed). 2024 Jul-Aug;44(4):584-585. doi: 10.1016/j.nefroe.2022.11.021. Epub 2022 Dec 7.

SGLT2 inhibitors: What role do they play in heart failure with reduced ejection fraction?钠-葡萄糖协同转运蛋白 2 抑制剂：在心衰射血分数降低患者中扮演何种角色？

Nurse Pract. 2021 Jul 1;46(7):30-37. doi: 10.1097/01.NPR.0000753832.85114.65.

Effects of empagliflozin on estimated extracellular volume, estimated plasma volume, and measured glomerular filtration rate in patients with heart failure (Empire HF Renal): a prespecified substudy of a double-blind, randomised, placebo-controlled trial.恩格列净对心力衰竭患者估算细胞外液量、估算血浆量和肾小球滤过率的影响（Empire HF Renal）：一项双盲、随机、安慰剂对照试验的预先指定亚研究。

Lancet Diabetes Endocrinol. 2021 Feb;9(2):106-116. doi: 10.1016/S2213-8587(20)30382-X. Epub 2020 Dec 22.

Obese or lean: Whom to prescribe sodium-glucose cotransporter 2 inhibitors in heart failure with preserved ejection fraction?肥胖或消瘦：射血分数保留的心力衰竭患者中该选用谁来处方钠-葡萄糖协同转运蛋白2抑制剂？

Eur J Heart Fail. 2024 Apr;26(4):910-911. doi: 10.1002/ejhf.3261. Epub 2024 Apr 28.

Early changes in estimated glomerular filtration rate post-initiation of empagliflozin in EMPEROR-Preserved.恩格列净起始治疗后在EMPEROR-Preserved研究中估算肾小球滤过率的早期变化

Eur J Heart Fail. 2024 Apr;26(4):885-896. doi: 10.1002/ejhf.3136. Epub 2024 Jan 21.

Effect of Sodium-Glucose Co-Transporter-2 Inhibitor on Estimated Plasma Volume in a Patient With Heart Failure With Reduced Ejection Fraction and a Patient With Heart Failure With Preserved Ejection Fraction.钠-葡萄糖共转运蛋白 2 抑制剂对射血分数降低的心力衰竭患者和射血分数保留的心力衰竭患者估算血浆容量的影响。

Clin Cardiol. 2024 Jul;47(7):e24303. doi: 10.1002/clc.24303.

A Meta-Analysis of the Sodium-Glucose Cotransporter 2 Inhibitors in Patients With Heart Failure and Preserved Ejection Fraction.射血分数保留的心力衰竭患者中钠-葡萄糖协同转运蛋白2抑制剂的荟萃分析

Am J Cardiol. 2022 Feb 1;164:138-141. doi: 10.1016/j.amjcard.2021.10.017. Epub 2021 Nov 17.

Differential Response to Low-Dose Dopamine or Low-Dose Nesiritide in Acute Heart Failure With Reduced or Preserved Ejection Fraction: Results From the ROSE AHF Trial (Renal Optimization Strategies Evaluation in Acute Heart Failure).射血分数降低或保留的急性心力衰竭患者对小剂量多巴胺或小剂量奈西立肽的不同反应：ROSE AHF试验（急性心力衰竭肾优化策略评估）结果

Circ Heart Fail. 2016 Aug;9(8). doi: 10.1161/CIRCHEARTFAILURE.115.002593.

SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials.钠-葡萄糖协同转运蛋白 2 抑制剂在射血分数降低的心力衰竭患者中的应用：EMPEROR-Reduced 和 DAPA-HF 试验的荟萃分析。

Lancet. 2020 Sep 19;396(10254):819-829. doi: 10.1016/S0140-6736(20)31824-9. Epub 2020 Aug 30.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验